Eli Lilly's Retatrutide Succeeds in Phase III, Analysts Concerned About Side Effects | Retatrutide News

Eli Lilly's Retatrutide has achieved positive outcomes in a Phase III trial, but analysts are worried about its adverse effects. This development is imp...
Clinical Trials · October 27, 2026